Russell P. “Rip” Wilson
Senior Vice President, Business Development

Russell P. Wilson Mr. Wilson joined Novavax in November 2011 as Senior Vice President, Business Development. He is responsible for developing business alliances, license arrangements, and partnering opportunities with pharmaceutical companies and government agencies. Mr. Wilson was most recently the Chief Financial Officer at Supernus Pharmaceuticals. He was previously Senior Vice President, Chief Financial Officer and General Counsel of Iomai Corporation, which was acquired in 2008 by Intercell AG, during which time he successfully negotiated a $128 million government contract with the Office of Biomedical Research and Development Authority (BARDA) at the U.S. Department of Health and Human Services. Mr. Wilson was also the Acting General Counsel of North American Vaccine, Inc. until its acquisition by Baxter International in 2000. He is a graduate of Princeton University and received his Master’s in Business Administration and Juris Doctorate degrees from the University of Virginia.